M M Odinak|D A Iskra - JoVE Visualize

Showing results (61-70 of 68) with videos related to

Pageof 7

Sort By:

You have reached the last page of results.This site can display upto 68 results.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 12, 2011

[Efficacy of cytoflavin in patients in the acute ischemic stroke]M M Odinak, V I Skvortsova, I A Vozniuk, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 12, 2009

[The structural and functional neurovisualization in patients with epileptic seizures in cerebro-vascular diseases]S N Bazilevich, M M Odinak, D E Dyskin, et al.

Voenno-Meditsinskii Zhurnal|July 16, 2016

[Multiple sclerosis vaccine: possibilities of the use of dendritic cells immunomodulatory potential]M M Odinak, G N Bisaga, V S Chirskii, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 6, 2007

[Tanakan (EGb 761) in the therapy of mild cognitive impairment]N N Iakhno, V V Zakharov, A B Lokshina, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 4, 2010

[Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment]S I Gavrilova, I V Kolykhalov, Ia B Fedorova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 5, 2017

[Levodopa-carbidopa intestinal gel in the treatment of patients with Parkinson disease: results of a 12-month open study]A A Skoromets, M M Odinak, E Z Yakupov, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020

[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis]E P Evdoshenko, N A Neofidov, K Z Bakhtiyarova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 1, 2017

[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study]A N Boyko, N Yu Lashch, S N Sharanova, et al.

Pageof 7

Showing results (61-70 of 68) with videos related to

Sort By:

Pageof 7

You have reached the last page of results.This site can display upto 68 results.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 12, 2011

[Efficacy of cytoflavin in patients in the acute ischemic stroke]M M Odinak, V I Skvortsova, I A Vozniuk, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 12, 2009

[The structural and functional neurovisualization in patients with epileptic seizures in cerebro-vascular diseases]S N Bazilevich, M M Odinak, D E Dyskin, et al.

Voenno-Meditsinskii Zhurnal|July 16, 2016

[Multiple sclerosis vaccine: possibilities of the use of dendritic cells immunomodulatory potential]M M Odinak, G N Bisaga, V S Chirskii, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 6, 2007

[Tanakan (EGb 761) in the therapy of mild cognitive impairment]N N Iakhno, V V Zakharov, A B Lokshina, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|May 4, 2010

[Possibilities of preventive treatment of Alzheimer's disease: results of the 3-year open prospective comparative study on efficacy and safety of the course therapy with cerebrolysin and cavinton in elderly patients with the syndrome of mild cognitive impairment]S I Gavrilova, I V Kolykhalov, Ia B Fedorova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|April 5, 2017

[Levodopa-carbidopa intestinal gel in the treatment of patients with Parkinson disease: results of a 12-month open study]A A Skoromets, M M Odinak, E Z Yakupov, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|January 15, 2020

[The efficacy and safety of siponimod in the Russian population of patients with secondary progressive multiple sclerosis]E P Evdoshenko, N A Neofidov, K Z Bakhtiyarova, et al.

Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|February 1, 2017

[Comparative, placebo-controlled clinical study of efficacy and safety of glatiramer acetate 20 mg in patients with relapsing-remitting multiple sclerosis: results of the first year of the study]A N Boyko, N Yu Lashch, S N Sharanova, et al.

Pageof 7